220 filings
6-K
EVGN
Evogene Ltd
30 Apr 24
Current report (foreign)
4:00pm
6-K
EVGN
Evogene Ltd
2 Apr 24
Current report (foreign)
7:00am
6-K
EVGN
Evogene Ltd
28 Mar 24
Current report (foreign)
4:45pm
6-K
EVGN
Evogene Ltd
20 Mar 24
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
9:00am
6-K
EVGN
Evogene Ltd
7 Mar 24
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
7:00am
6-K
0n5 zzlsg4
22 Feb 24
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan
7:00am
6-K
qdit1qc 0mgv
21 Feb 24
AgPlenus Announces Licensing & Collaboration Agreement with Bayer
7:01am
6-K
7m7ju2diagx
17 Jan 24
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
7:00am
6-K
haqifm196mk8pn6hv
9 Jan 24
Current report (foreign)
8:30am
6-K
xgwngj98cplku8k4d4
19 Dec 23
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
7:00am
6-K
bw80o
15 Nov 23
Evogene Reports Third Quarter 2023 Financial Results
7:00am
6-K
c5m1bsu3c5zv2yld7j5y
8 Nov 23
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy
7:00am
6-K
55khjqvj df3basafe
21 Sep 23
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
7:00am
6-K
y27w0d bh
19 Sep 23
Company Presentation Eyal Ronen, CEO September 2023
7:15am
6-K
bw734e3avxo
13 Sep 23
Current report (foreign)
7:00am
6-K
3r4vxzia6
23 Aug 23
Current report (foreign)
7:00am
6-K
ijq8p8z
17 Aug 23
Evogene Reports Second Quarter 2023 Financial Results
7:00am
6-K
1zibp11u6n
8 Aug 23
Company Presentation August 2023
7:30am
6-K
eze6p41l56
17 Jul 23
Current report (foreign)
8:15am
6-K
bu4u37uzh5xqrytuu
17 Jul 23
Current report (foreign)
8:00am